Rivaroxaban-Mepha
Rivaroxaban-Mepha is a generic from Mepha Pharma AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 16.90 to CHF 74.80 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Mepha Pharma AG
- ATC code
- B01AF01
- IT group
- 06.03.40 Faktor-Xa-Inhibitoren
- Active substances
- Rivaroxabanum
- Preparation type
- Generic
- On the SL since
- 01/08/2024
- Last price change
- 01/08/2025
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Filmtabl 10 mg | Blist 14 Stk | CHF 7.02 | CHF 16.90 | 01/08/2024 | B | 7680684390012 |
| Filmtabl 10 mg | Blist 28 Stk | CHF 14.05 | CHF 32.05 | 01/08/2024 | B | 7680684390029 |
| Filmtabl 10 mg | Blist 98 Stk | CHF 51.65 | CHF 73.70 | 01/08/2024 | B | 7680684390036 |
| Filmtabl 10 mg | Ds 100 Stk | CHF 52.70 | CHF 74.80 | 01/08/2024 | B | 7680684390043 |
| Filmtabl 15 mg | Blist 14 Stk | CHF 7.21 | CHF 24.40 | 01/08/2024 | B | 7680684390050 |
| Filmtabl 15 mg | Blist 28 Stk | CHF 14.08 | CHF 32.00 | 01/08/2024 | B | 7680684390067 |
| Filmtabl 15 mg | Blist 98 Stk | CHF 51.65 | CHF 73.70 | 01/08/2024 | B | 7680684390074 |
| Filmtabl 15 mg | Ds 100 Stk | CHF 52.70 | CHF 74.75 | 01/08/2024 | B | 7680684390128 |
| Filmtabl 20 mg | Blist 14 Stk | CHF 7.25 | CHF 24.45 | 01/08/2024 | B | 7680684390081 |
| Filmtabl 20 mg | Blist 28 Stk | CHF 14.08 | CHF 32.00 | 01/08/2024 | B | 7680684390098 |
| Filmtabl 20 mg | Blist 98 Stk | CHF 51.65 | CHF 73.70 | 01/08/2024 | B | 7680684390104 |
| Filmtabl 20 mg | Ds 100 Stk | CHF 52.70 | CHF 74.75 | 01/08/2024 | B | 7680684390111 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
More preparations in this group
FAQ
Is Rivaroxaban-Mepha covered by Swiss health insurance?
Yes, but only under conditions. Rivaroxaban-Mepha is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Rivaroxaban-Mepha cost in Switzerland?
The public price is the maximum price set by the FOPH and for Rivaroxaban-Mepha ranges from CHF 16.90 to CHF 74.80 per pack. The ex-factory price ranges from CHF 7.02 to CHF 52.70. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages